The first centres to treat patients with stereotactic ablative radiotherapy (SABR), as part of NHS England’s latest national evaluation programme, will be able to start accepting patients from today (Monday). NHS England has invested £15m over three years to assess the use of SABR through its Commissioning through Evaluation initiative, which will allow up to […]
NHS England is seeking people’s views on proposed changes to the shape of Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) services across the country. SRS and SRT are forms of radiotherapy used to treat patients with intracranial conditions such as brain tumours. NHS England took on responsibility for commissioning these services in April 2013 and […]
NHS England has announced the list of provider hospitals chosen to take part in a new £4.8 million initiative, aimed at increasing access to specialist radiotherapy services. The 10 centres will provide Selective Internal Radiotherapy (SIRT) to around 220 patients a year as part of a time-limited programme called ‘Commissioning through Evaluation’. The successful centres […]
Manufacturers of radiotherapy equipment who are planning innovations that may change the shape of cancer care are to pitch to NHS England, Cancer Research UK and radiotherapy experts in a dragons-den style event to show the latest products available for carrying out innovative radiotherapies. The event, which takes place on the 8th and 9th October, […]
NHS England will commission radiosurgery or radiotherapy for the treatment of cavernous venous malformations (cavernomas) in accordance with the criteria outlined in this document.
Selective Internal Radiotherapy (SIRT) is not recommended to be available as a routine commissioning treatment option for the treatment of (1) neuroendocrine tumour liver metastases (NETLM); (2) liver metastases of other less common radiotherapy sensitive tumours, within the criteria set out in this document.
NHS England will commission stereotactic radiosurgery (SRS) or stereotactic radiotherapy (SRT) for the treatment of cerebral metastases in accordance with the criteria outlined in this document.
In this blog, shared for Healthcare Science Week (11 to 15 March 2024), Professor Dame Sue Hill, Chief Scientific Officer for NHS England considers how healthcare science has shaped the NHS to meet new challenges. This week is Healthcare Science Week, a celebration of healthcare science, bringing together over 50 scientific specialisms. With a focus […]
Thousands of women are being urged to attend NHS breast screening appointments as new figures today show that, despite a slight increase in uptake in the last year, over a third of women still did not take up the potentially lifesaving offer. In 2022-23, a total of 1.93 million women aged 50 to 70 (64.6%) […]
Hundreds of people with an aggressive type of blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a potentially curative new treatment option on the NHS, with approval of the drug glofitamab. Glofitamab (also called Columvi®) is to be made available for patients with previously treated DLBCL which is a […]